AperçuGraphiqueActualitésTraderScreen

Reata Pharmaceuticals/  US75615P1030  /

NASDAQ
25/09/2023  22:00:00 Chg. - Volume Bid01:50:00 Demandez à01:50:00 Haut Bas
172.3600USD - 1.99 Mio.
Chiffrre d'affaires: 301.65 Mio.		 172.3600Bid taille: - 172.5000Ask la taille: - 172.4600 172.3200
GlobeNewswire 22:10 BioRestorative Therapies Provides First Quarter 2024 Business Update
GlobeNewswire 22:10 Expion360 Reports First Quarter 2024 Financial Results
GlobeNewswire 22:10 Atlanticus Announces Approval of Quarterly Preferred Stock Dividend
GlobeNewswire 22:10 Dragonfly Energy Reports First Quarter 2024 Financial and Operational Results
GlobeNewswire 22:10 GENFIT Reports First Quarter 2024 Financial Information
GlobeNewswire 22:07 Bridgeline Announces Financial Results for the Second Quarter of Fiscal 2024
GlobeNewswire 22:06 dLocal Reports 2024 First Quarter Financial Results
GlobeNewswire 22:06 Fanatics Sportsbook Cheers on Justin Thomas in his Home State of Kentucky
GlobeNewswire 22:06 Flywire improves efficiency and cash flow for higher education institutions with expanded availabili...
GlobeNewswire 22:05 CNB Financial Corporation Announces Quarterly Dividend for Common Stock
GlobeNewswire 22:05 ATA Creativity Global Reports First Quarter 2024 Financial Results
GlobeNewswire 22:05 Infinera Corporation Reports Preliminary First Quarter 2024 Financial Results
GlobeNewswire 22:05 Udemy to Present at the J.P. Morgan Annual Global Technology, Media and Communications Conference
GlobeNewswire 22:05 iPower Reports Fiscal Third Quarter 2024 Results
GlobeNewswire 22:05 Fiverr to Present at Upcoming Conference
GlobeNewswire 22:05 SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 22:05 Canoo Inc. Announces First Quarter 2024 Results
GlobeNewswire 22:05 Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update
GlobeNewswire 22:05 RYVYL Reports Q1 2024 Results
GlobeNewswire 22:05 Motus GI Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 22:05 Reed’s Reports First Quarter 2024 Results
GlobeNewswire 22:05 The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Gui...
GlobeNewswire 22:05 NeuroPace to Participate in Two Healthcare Conferences in May
GlobeNewswire 22:05 TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
GlobeNewswire 22:05 Nasdaq Announces 2024 Annual Meeting of Shareholders